Literature DB >> 8078785

[Heart involvement in progressive spinal muscular atrophy. A review of the literature and case histories in childhood].

G Distefano1, P Sciacca, M G Parisi, E Parano, P Smilari, M Marletta, A Fiumara.   

Abstract

There are few cardiological studies in progressive spinal muscular atrophy and mainly concern subjects affected by the juvenile form (Kugelberg-Welander disease). The presence of a cardiomyopathy has been reported in these patients but the cardiac involvement is often secondary to the chronic respiratory insufficiency typical of the disease. We performed a retrospective study in our Institute on 43 patients, age range 3 months to 3 years, 37 of which presented type I (Werdnig-Hoffmann disease) and 6 type II (intermediate form) of the disease. No clinical nor instrumental signs of cardiomyopathy were observed. However, ECG revealed signs of right ventricular overload in 37.3% of the patients, probably provoked by pulmonary hypertension due to respiration anomalies. The authors underline the importance of correct respiratory assistance to prevent onset of cardiological alterations.

Entities:  

Mesh:

Year:  1994        PMID: 8078785

Source DB:  PubMed          Journal:  Pediatr Med Chir        ISSN: 0391-5387


  9 in total

1.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

Review 2.  Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Authors:  Chiara Simone; Agnese Ramirez; Monica Bucchia; Paola Rinchetti; Hardy Rideout; Dimitra Papadimitriou; Diane B Re; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2015-12-18       Impact factor: 9.261

3.  SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA.

Authors:  Vicki L McGovern; Chitra C Iyer; W David Arnold; Sara E Gombash; Phillip G Zaworski; Anton J Blatnik; Kevin D Foust; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-07-23       Impact factor: 6.150

4.  The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.

Authors:  W Arnold; Vicki L McGovern; Benjamin Sanchez; Jia Li; Kaitlyn M Corlett; Stephen J Kolb; Seward B Rutkove; Arthur H Burghes
Journal:  Neurobiol Dis       Date:  2015-12-28       Impact factor: 5.996

Review 5.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

6.  Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy.

Authors:  Gillian K Maxwell; Eva Szunyogova; Hannah K Shorrock; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2018-02-22       Impact factor: 2.610

7.  Cardiac involvement in patients with spinal muscular atrophies.

Authors:  Alberto Palladino; Luigia Passamano; Antonella Taglia; Paola D'Ambrosio; Marianna Scutifero; Maria Rosaria Cecio; Esther Picillo; Emanuela Viggiano; Vito Torre; Francesco De Luca; Giovanni Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2011-12

Review 8.  Spinal muscular atrophy: from tissue specificity to therapeutic strategies.

Authors:  Daniel M Iascone; Christopher E Henderson; Justin C Lee
Journal:  F1000Prime Rep       Date:  2015-01-05

9.  Survival Motor Neuron (SMN) protein is required for normal mouse liver development.

Authors:  Eva Szunyogova; Haiyan Zhou; Gillian K Maxwell; Rachael A Powis; Francesco Muntoni; Thomas H Gillingwater; Simon H Parson
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.